Skip to main content

Advertisement

SpringerLink
Log in

Next-generation proteasome inhibitor approved in multiple myeloma

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. New York

    Alla Katsnelson

Authors
  1. Alla Katsnelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Katsnelson, A. Next-generation proteasome inhibitor approved in multiple myeloma. Nat Biotechnol 30, 1011–1012 (2012). https://doi.org/10.1038/nbt1112-1011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1112-1011

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation